<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments for Wexler Wallace</title>
	<atom:link href="http://www.wexlerwallace.com/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.wexlerwallace.com</link>
	<description></description>
	<lastBuildDate>Thu, 08 Dec 2011 21:04:29 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>Comment on Meth v. Facebook by A Topical Index of Facebook Lawsuits &#171; Mass. Consumer Law &#38; Consumer Protection News</title>
		<link>http://www.wexlerwallace.com/cases/meth-v-facebook/#comment-66</link>
		<dc:creator>A Topical Index of Facebook Lawsuits &#171; Mass. Consumer Law &#38; Consumer Protection News</dc:creator>
		<pubDate>Thu, 08 Dec 2011 21:04:29 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=1397#comment-66</guid>
		<description>[...] Meth v Facebook &#8212; alleged fb&#8217;s unauthorized use of minors’ names and/or likenesses without parental consent. [...]</description>
		<content:encoded><![CDATA[<p>[...] Meth v Facebook &#8212; alleged fb&#8217;s unauthorized use of minors’ names and/or likenesses without parental consent. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Amber M. Nesbitt by Amber Nesbitt, Mark Miller Selected as Rising Stars &#171; Wexler Wallace</title>
		<link>http://www.wexlerwallace.com/our-firm/our-professionals/amber-m-nesbitt/#comment-61</link>
		<dc:creator>Amber Nesbitt, Mark Miller Selected as Rising Stars &#171; Wexler Wallace</dc:creator>
		<pubDate>Tue, 25 Oct 2011 21:35:42 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=355#comment-61</guid>
		<description>[...] Wallace is pleased to announce that Amber Nesbitt and Mark Miller have been selected as Rising Stars for inclusion in Super Lawyers magazine’s [...]</description>
		<content:encoded><![CDATA[<p>[...] Wallace is pleased to announce that Amber Nesbitt and Mark Miller have been selected as Rising Stars for inclusion in Super Lawyers magazine’s [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on In re Wellbutrin XL Indirect Purchaser Antitrust Litigation by Kenneth A. Wexler – Attorney &#124; Commercial Litigation &#124; Securities &#124; Antitrust &#124; Healthcare</title>
		<link>http://www.wexlerwallace.com/cases/in-re-wellbutrin-xl-indirect-purchaser-antitrust-litigation/#comment-60</link>
		<dc:creator>Kenneth A. Wexler – Attorney &#124; Commercial Litigation &#124; Securities &#124; Antitrust &#124; Healthcare</dc:creator>
		<pubDate>Tue, 25 Oct 2011 21:33:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=479#comment-60</guid>
		<description>[...] In re Wellbutrin XL Indirect Purchaser Antitrust Litigation, Case No. 2:08-CV-02433-MAM (E.D. Pa.): On August 15, 2011, Ken was appointed co-lead counsel of the indirect purchaser class, which consists of third party payors and certain consumers which purchased Wellbutrin XL and its generic (once available) from November 14, 2005 to April 29, 2011 in six states: California, Florida, Nevada, New York, Tennessee, and Wisconsin.  Ken was appointed as co-lead counsel, along with Richard Cohen and Peter St. Philip of Lowey Dannenberg Cohen &amp; Hart, as well as Jim G. Stranch and Joe P. Leniski , Jr.  of Branstetter, Stranch, &amp; Jennings. [...]</description>
		<content:encoded><![CDATA[<p>[...] In re Wellbutrin XL Indirect Purchaser Antitrust Litigation, Case No. 2:08-CV-02433-MAM (E.D. Pa.): On August 15, 2011, Ken was appointed co-lead counsel of the indirect purchaser class, which consists of third party payors and certain consumers which purchased Wellbutrin XL and its generic (once available) from November 14, 2005 to April 29, 2011 in six states: California, Florida, Nevada, New York, Tennessee, and Wisconsin.  Ken was appointed as co-lead counsel, along with Richard Cohen and Peter St. Philip of Lowey Dannenberg Cohen &amp; Hart, as well as Jim G. Stranch and Joe P. Leniski , Jr.  of Branstetter, Stranch, &amp; Jennings. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on In re Wellbutrin XL Indirect Purchaser Antitrust Litigation by Amber M. Nesbitt - Attorney &#124; Securities &#124; Consumer Fraud &#124; Antitrust &#124; Healthcare &#124; Antitrust</title>
		<link>http://www.wexlerwallace.com/cases/in-re-wellbutrin-xl-indirect-purchaser-antitrust-litigation/#comment-59</link>
		<dc:creator>Amber M. Nesbitt - Attorney &#124; Securities &#124; Consumer Fraud &#124; Antitrust &#124; Healthcare &#124; Antitrust</dc:creator>
		<pubDate>Tue, 25 Oct 2011 21:29:07 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=479#comment-59</guid>
		<description>[...] In re Wellbutrin XL Indirect Purchaser Antitrust Litigation, Case No. 2:08-CV-02433-MAM (E.D. Penn.)... On August 15, 2011, Amber was appointed co-lead counsel of the indirect purchaser class, which consists of third party payors and certain consumers which purchased Wellbutrin XL and its generic (once available) from November 14, 2005 to April 29, 2011 in six states: California, Florida, Nevada, New York, Tennessee, and Wisconsin.  Kenneth A. Wexler also was appointed as co-lead counsel, along with Richard Cohen and Peter St. Philip of Lowey Dannenberg Cohen &amp; Hart, as well as Jim G. Stranch and Joe P. Leniski , Jr.  of Branstetter, Stranch, &amp; Jennings. [...]</description>
		<content:encoded><![CDATA[<p>[...] In re Wellbutrin XL Indirect Purchaser Antitrust Litigation, Case No. 2:08-CV-02433-MAM (E.D. Penn.)&#8230; On August 15, 2011, Amber was appointed co-lead counsel of the indirect purchaser class, which consists of third party payors and certain consumers which purchased Wellbutrin XL and its generic (once available) from November 14, 2005 to April 29, 2011 in six states: California, Florida, Nevada, New York, Tennessee, and Wisconsin.  Kenneth A. Wexler also was appointed as co-lead counsel, along with Richard Cohen and Peter St. Philip of Lowey Dannenberg Cohen &amp; Hart, as well as Jim G. Stranch and Joe P. Leniski , Jr.  of Branstetter, Stranch, &amp; Jennings. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Paxil Litigation &#8212; Nichols et al. v. Smithkline Beecham et al. by Kenneth A. Wexler – Attorney &#124; Commercial Litigation &#124; Securities &#124; Antitrust &#124; Healthcare</title>
		<link>http://www.wexlerwallace.com/cases/paxil-litigation-nichols-et-al-v-smithkline-beecham-et-al/#comment-58</link>
		<dc:creator>Kenneth A. Wexler – Attorney &#124; Commercial Litigation &#124; Securities &#124; Antitrust &#124; Healthcare</dc:creator>
		<pubDate>Tue, 25 Oct 2011 21:27:13 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=494#comment-58</guid>
		<description>[...] Paxil Litigation &#8211; Nichols v. SmithKline Beecham Corp., Case No. 2:00-CV-06222-JP (E.D. Pa.). An antitrust case in which Plaintiffs alleged that several of Defendants&#8217; patents for paroxetine hydrochloride were improperly listed in the FDA Orange Book and that Defendants&#8217; patent infringement litigation against various generic drug manufacturers was &#8220;sham&#8221; litigation designed to keep generic versions of Paxil® off the market. Ken, as one of three Co-Lead Counsel, had to build the Paxil case from the ground up. The Paxil litigation is believed to be one of the first, if not the first, to allege misuse of patents to delay generic competition in a pharmaceutical market brought under Section 2 of the Sherman Act rather than Section 1. Despite these hurdles, and after extensive discovery and investigation, the case settled for $65 million in cash. The favorable response to this hard-fought settlement was overwhelming – over 60,000 consumers filed claims.  Read more. [...]</description>
		<content:encoded><![CDATA[<p>[...] Paxil Litigation &#8211; Nichols v. SmithKline Beecham Corp., Case No. 2:00-CV-06222-JP (E.D. Pa.). An antitrust case in which Plaintiffs alleged that several of Defendants&#8217; patents for paroxetine hydrochloride were improperly listed in the FDA Orange Book and that Defendants&#8217; patent infringement litigation against various generic drug manufacturers was &#8220;sham&#8221; litigation designed to keep generic versions of Paxil® off the market. Ken, as one of three Co-Lead Counsel, had to build the Paxil case from the ground up. The Paxil litigation is believed to be one of the first, if not the first, to allege misuse of patents to delay generic competition in a pharmaceutical market brought under Section 2 of the Sherman Act rather than Section 1. Despite these hurdles, and after extensive discovery and investigation, the case settled for $65 million in cash. The favorable response to this hard-fought settlement was overwhelming – over 60,000 consumers filed claims.  Read more. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Ask About a Case by Wexler Wallace</title>
		<link>http://www.wexlerwallace.com/contact-us/ask-about-a-case/#comment-57</link>
		<dc:creator>Wexler Wallace</dc:creator>
		<pubDate>Thu, 20 Oct 2011 14:31:11 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?page_id=65#comment-57</guid>
		<description>[...] ask about a case report your concern our professionals [...]</description>
		<content:encoded><![CDATA[<p>[...] ask about a case report your concern our professionals [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on IFDA: Illinois Funeral Directors Association &#8212; Multiple Cases by Suit alleges funeral fund conspiracy</title>
		<link>http://www.wexlerwallace.com/cases/ifda-illinois-funeral-directors-association-multiple-cases/#comment-13</link>
		<dc:creator>Suit alleges funeral fund conspiracy</dc:creator>
		<pubDate>Tue, 01 Mar 2011 17:31:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=1059#comment-13</guid>
		<description>[...] IFDA: Illinois Funeral Directors Association — Multiple Cases &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] IFDA: Illinois Funeral Directors Association — Multiple Cases &#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on AWP Litigation &#8212; In re Pharmaceutical Industry Average Wholesale Price Litigation by Judge Enters Formal Order on AstraZeneca &#171; Wexler Wallace</title>
		<link>http://www.wexlerwallace.com/cases/awp-litigation-in-re-pharmaceutical-industry-average-wholesale-price-litigation/#comment-12</link>
		<dc:creator>Judge Enters Formal Order on AstraZeneca &#171; Wexler Wallace</dc:creator>
		<pubDate>Thu, 24 Feb 2011 00:40:24 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=539#comment-12</guid>
		<description>[...] defendants.   To read more about the AWP litigation, in which Wexler Wallace is co-lead counsel, click here.           &#169; Copyright 2011 Wexler Wallace LLP &#124; 55 W. Monroe St. Ste. 3300 &#124; Chicago, IL [...]</description>
		<content:encoded><![CDATA[<p>[...] defendants.   To read more about the AWP litigation, in which Wexler Wallace is co-lead counsel, click here.           &copy; Copyright 2011 Wexler Wallace LLP | 55 W. Monroe St. Ste. 3300 | Chicago, IL [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Meth v. Facebook by Internet Evolution - Robert McGarvey - Facebook's Top Lawsuits Target User Privacy</title>
		<link>http://www.wexlerwallace.com/cases/meth-v-facebook/#comment-11</link>
		<dc:creator>Internet Evolution - Robert McGarvey - Facebook's Top Lawsuits Target User Privacy</dc:creator>
		<pubDate>Tue, 22 Feb 2011 19:08:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?p=1397#comment-11</guid>
		<description>[...]  [...]</description>
		<content:encoded><![CDATA[<p>[...]  [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Ask About a Case by Meth v. Facebook &#171; Wexler Wallace</title>
		<link>http://www.wexlerwallace.com/contact-us/ask-about-a-case/#comment-10</link>
		<dc:creator>Meth v. Facebook &#171; Wexler Wallace</dc:creator>
		<pubDate>Fri, 18 Feb 2011 15:10:02 +0000</pubDate>
		<guid isPermaLink="false">http://www.wexlerwallace.com/?page_id=65#comment-10</guid>
		<description>[...]  ask about a case report your concern our [...]</description>
		<content:encoded><![CDATA[<p>[...]  ask about a case report your concern our [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

